|
|
| |
|
|
|
|
|
|
13635 |
±¤ÁÖ |
´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ 106Â÷ Çмú Áý´ãȸ : 2022-09-23 |
0 |
165 |
2022-08-30 |
|
|
|
13634 |
´ë±¸ |
KSC 2022 (´ëÇѽÉÀåÇÐȸ Á¦66Â÷ Ãß°èÇмú´ëȸ)(1ÀÏÂ÷) : 2022-09-23 |
0 |
671 |
2022-08-30 |
|
|
|
13633 |
°æ±â |
Çϳ²½ÃÀÇ»çȸ¿¬¼ö°ÁÂ(Äڷγª¹ÙÀÌ·¯½º Ä¡·á¿Í ¹é½Å) : 2022-09-23 |
0 |
143 |
2022-08-30 |
|
|
|
13632 |
Àü³² |
2022 ¿©¼ö½ÃÀÇ»çȸ ÈĹݱâ Çмú´ëȸ(¼ö¸éÀå¾Ö, ´ç´¢º´) : 2022-09-23 |
0 |
281 |
2022-08-30 |
|
|
|
13631 |
±¤ÁÖ |
´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Hypnosis vs. meditation ; ACT-oriented hypnotherapy : 2022-09-22 |
0 |
102 |
2022-08-30 |
|
|
|
13630 |
ºÎ»ê |
´ëÇÑ»êºÎÀΰúÇÐȸ ºÎ»êÁöȸ 9¿ù Çмú¸ðÀÓ : 2022-09-22 |
0 |
145 |
2022-08-30 |
|
|
|
13629 |
¼¿ï |
´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) AACA 2022 Á¦4Â÷ Pre-congress : 2022-09-22 |
0 |
442 |
2022-08-30 |
|
|
|
13628 |
¼¿ï |
(¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼¿ïÁöȸ Áý´ãȸ : 2022-09-22 |
0 |
199 |
2022-08-30 |
|
|
|
13627 |
¼¿ï |
´ëÇÑÀÓ»ó°Ë»çÁ¤µµ°ü¸®ÇÐȸ 2022³âµµ Ãß°èÇмú´ëȸ : 2022-09-20 |
0 |
249 |
2022-08-30 |
|
|
|
13626 |
ºÎ»ê |
2022³âµµ ´ëÇÑÁ¤½Å°Ç°ÀÇÇаúÀÇ»çȸ ¿¬¼ö°Á : 2022-09-20 |
0 |
135 |
2022-08-30 |
|
|
|
13625 |
´ëÀü |
´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 9¿ù ¿¬¼ö°Á : 2022-09-20 |
0 |
180 |
2022-08-30 |
|
|
|
13624 |
ºÎ»ê |
(¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°ú ºÎ»ê․¿ï»ê․°æ³²Áöȸ Á¦349Â÷ ¿Â¶óÀÎ ¿ù·ÊÇмúȸ : 2022-09-20 |
0 |
114 |
2022-08-30 |
|
|
|
13623 |
¼¿ï |
°í·Á´ëÇб³±¸·Îº´¿ø È£Èí±â³»°ú ÄÚȣƮ °£´ãȸ(¸¸¼º±âħ, COPD Áø´Ü°ú Ä¡·á) : 2022-09-20 |
0 |
199 |
2022-08-30 |
|
|
|
13622 |
´ë±¸ |
´ëÇÑÀçÈ°ÀÇÇÐȸ 107Â÷ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2022-09-20 |
0 |
112 |
2022-08-30 |
|
|
|
13621 |
´ëÀü |
´ëÇѺñ´¢ÀÇÇÐȸ Symphosium - PSA in BPH and peyronie's disease : 2022-09-19 |
0 |
101 |
2022-08-30 |
|
|